< Back to previous page

Project

In English: REMOTE: The added value of mobile technology for the early detection of atrial fibrillation in the care path of cryptogenic stroke patients (R-11203)

Cryptogenic stroke and transient ischemic attack (TIA) patients have no determined etiology at discharge and comprise 25-30% of all stroke and TIA patients. Atrial fibrillation (AF) is a risk factor for stroke and TIA that often goes undetected. AF-related strokes have a higher burden on the patient and the healthcare system. Furthermore, stroke recurrence remains a substantial problem as 9% of patients endure a recurrence after six months, and 14-21% after two years. The risk of AF can be considerably reduced by oral anticoagulation (OAC). However, AF has to be documented for at least 30 seconds prior to OAC therapy initiation. Insertable cardiac monitors (ICMs) are the state-of-the-art as they continuously monitor the heart rhythm for three years. However, due to their high costs and invasiveness, they are underutilized. Therefore, mobile health (mHealth) can be a feasible alternative to ICMs to reduce the risk of stroke recurrence due to AF. In this project, we will determine the added value of mHealth in the care path for the early detection of AF in cryptogenic stroke patients. Therefore, the current view of mHealth in follow-up will be investigated. The yield of AF detection using mHealth and the associated costs will be determined. Finally, the risk stratification that could improve the care path will be identified. As such, this new proof-of-concept care path can lead to improved treatment and a decrease in recurrence, patient morbidity and mortality.
Date:1 Feb 2021 →  31 Jan 2024
Keywords:Cardiovascular disease
Disciplines:Cardiology, Vascular diseases, Health economy, Medical device usage, Diagnostics not elsewhere classified